Rebecca F McClure

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi request reprint JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance
    Alexandra P Wolanskyj
    Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
    Br J Haematol 131:208-13. 2005
  2. ncbi request reprint Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior
    Rebecca F McClure
    Department of Laboratory Medicine and Pathology, Divisions of Anatomic Pathology and Hematopathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 29:1652-60. 2005
  3. doi request reprint Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders
    Andrew P Sciallis
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
    Mod Pathol 25:983-92. 2012
  4. doi request reprint Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies
    Animesh Pardanani
    Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
    Blood 114:3769-72. 2009
  5. pmc PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus
    Andrew L Feldman
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Mod Pathol 23:593-602. 2010
  6. doi request reprint Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
    Ken Hong Lim
    Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
    Blood 113:5727-36. 2009
  7. pmc A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization
    Sarah F Paternoster
    Division of Laboratory Genetics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    Am J Pathol 160:1967-72. 2002
  8. ncbi request reprint Lenalidomide therapy in myelofibrosis with myeloid metaplasia
    Ayalew Tefferi
    Division of Hematology and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Blood 108:1158-64. 2006
  9. ncbi request reprint Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors
    Alexandra P Wolanskyj
    Division of Hematology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 81:159-66. 2006
  10. doi request reprint 20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis
    Ayalew Tefferi
    Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
    Eur J Haematol 80:386-90. 2008

Collaborators

Detail Information

Publications19

  1. ncbi request reprint JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance
    Alexandra P Wolanskyj
    Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
    Br J Haematol 131:208-13. 2005
    ..Therefore, although the presence of JAK2(V617F) in ET appears to promote a PV phenotype, it might not carry treatment-relevant information...
  2. ncbi request reprint Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior
    Rebecca F McClure
    Department of Laboratory Medicine and Pathology, Divisions of Anatomic Pathology and Hematopathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 29:1652-60. 2005
    ....
  3. doi request reprint Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders
    Andrew P Sciallis
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
    Mod Pathol 25:983-92. 2012
    ..Understanding the spectrum of mucosal CD30-positive T-cell lymphoproliferations is important to avoid possible overtreatment resulting from a diagnosis of overt T-cell lymphoma...
  4. doi request reprint Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies
    Animesh Pardanani
    Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
    Blood 114:3769-72. 2009
    ....
  5. pmc PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus
    Andrew L Feldman
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Mod Pathol 23:593-602. 2010
    ..As PAX5 overexpression causes T-cell neoplasms in experimental models, PAX5 may have contributed to lymphomagenesis in our cases...
  6. doi request reprint Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
    Ken Hong Lim
    Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
    Blood 113:5727-36. 2009
    ..The current study validates the prognostic relevance of the WHO subclassification of SM and provides additional information of value in terms of both risk stratification and interpretation of clinical presentation and laboratory results...
  7. pmc A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization
    Sarah F Paternoster
    Division of Laboratory Genetics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    Am J Pathol 160:1967-72. 2002
    ..This FISH technique is useful to detect chromosome anomalies with high sensitivity and specificity in paraffin-embedded tissue and may provide important diagnostic and prognostic genetic information...
  8. ncbi request reprint Lenalidomide therapy in myelofibrosis with myeloid metaplasia
    Ayalew Tefferi
    Division of Hematology and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Blood 108:1158-64. 2006
    ..We conclude that lenalidomide engenders an intriguing treatment activity in a subset of patients with MMM that includes an unprecedented effect on peripheral blood and bone marrow abnormalities...
  9. ncbi request reprint Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors
    Alexandra P Wolanskyj
    Division of Hematology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 81:159-66. 2006
    ....
  10. doi request reprint 20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis
    Ayalew Tefferi
    Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
    Eur J Haematol 80:386-90. 2008
    ....
  11. doi request reprint Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior
    Karen L Grogg
    Department of Laboratory Medicine and Pathology, Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Mod Pathol 21:708-15. 2008
    ..In patients with isolated cutaneous lesions, the indolent behavior of this rare T-cell neoplasm should be recognized to avoid unnecessary treatment...
  12. ncbi request reprint MPL W515 and JAK2 V617 mutation analysis in patients with refractory anemia with ringed sideroblasts and an elevated platelet count
    David P Steensma
    Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Haematologica 91:ECR57. 2006
    ....
  13. ncbi request reprint MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients
    Animesh D Pardanani
    Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Blood 108:3472-6. 2006
    ..Furthermore, MPL mutations may occur concurrently with the JAK2V617F mutation, suggesting that these alleles may have functional complementation in myeloproliferative disease...
  14. doi request reprint Epstein-Barr virus-associated diffuse large B-cell lymphoma arising on cardiac prostheses
    Dylan V Miller
    Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA
    Am J Surg Pathol 34:377-84. 2010
    ....
  15. ncbi request reprint Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications
    Natalia Gonzalez-Paz
    Department of Hematology, Mayo Clinic College of Medicine, Rochester, MN, USA
    Blood 109:1228-32. 2007
    ....
  16. ncbi request reprint The JAK2 V617F mutation is absent in patients with erythrocytosis due to high oxygen affinity hemoglobin variants
    Rebecca F McClure
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Hemoglobin 30:487-9. 2006
    ..All specimens showed the absence of this mutation. This observation contributes to the overall clinical specificity of the JAK2 V617F mutation...
  17. ncbi request reprint Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over time
    Terra L Lasho
    Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
    Br J Haematol 135:683-7. 2006
    ..We conclude that MPLW515L/K and JAK2V617F are both early events in MMM and allele burden, rather than the mere presence of these mutations, might be relevant to phenotypic variation in myeloproliferative disorders...
  18. ncbi request reprint Agnogenic myeloid metaplasia with pleural extramedullary leukemic transformation
    Hassan F Nadrous
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Leuk Lymphoma 45:815-8. 2004
    ..He was hospitalized for neutropenic fever and was diagnosed to have pulmonary aspergillosis. He died of multisystem failure 8 1/2 months after being diagnosed with AMM...
  19. pmc The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes
    David P Steensma
    Mayo Clinic and Mayo Clinic College of Medicine, Rochester MN 55905, USA
    Blood 106:1207-9. 2005
    ..The current observation strengthens the specific association between JAK2 V617F and classic MPD, but also suggests an infrequent occurrence in other myeloid disorders...